News
TLPPF
9.15
NaN%
--
Weekly Report: what happened at TLPPF last week (1102-1106)?
Weekly Report · 11/09 09:30
Canaccord Genuity Reaffirms Their Buy Rating on Telix Pharmaceuticals (TLPPF)
TipRanks · 11/08 22:35
Analysts Offer Insights on Healthcare Companies: Telix Pharmaceuticals (OtherTLPPF) and Universal Health (UHS)
TipRanks · 11/06 00:20
Citi Reaffirms Their Buy Rating on Telix Pharmaceuticals (TLPPF)
TipRanks · 11/04 22:35
UBS Sticks to Their Buy Rating for Telix Pharmaceuticals (TLPPF)
TipRanks · 11/04 22:35
Telix Director Maria Rivas Acquires 9,000 ADSs
TipRanks · 11/04 22:19
Telix Director Acquires Shares and NED Rights
TipRanks · 11/03 08:25
Telix Issues 1,095 Unquoted NED Share Rights
TipRanks · 11/03 07:46
Weekly Report: what happened at TLPPF last week (1026-1030)?
Weekly Report · 11/02 09:30
Telix Seeks ASX Quotation for New Director Equity Issue
TipRanks · 10/28 06:38
Telix Pharmaceuticals (TLPPF) Gets a Buy from Citi
TipRanks · 10/27 00:26
Ord Minnett Remains a Buy on Telix Pharmaceuticals (TLPPF)
TipRanks · 10/27 00:15
Telix CEO Adds to Shareholding, Underscoring Equity Alignment
TipRanks · 10/26 22:38
Weekly Report: what happened at TLPPF last week (1019-1023)?
Weekly Report · 10/26 09:30
Telix Director Increases Nasdaq ADS Holding in Routine Portfolio Move
TipRanks · 10/25 23:50
Telix Pharmaceuticals (TLPPF) Receives a Buy from Jarden
TipRanks · 10/23 01:47
Analysts Offer Insights on Healthcare Companies: Thermo Fisher (TMO) and Telix Pharmaceuticals (OtherTLPPF)
TipRanks · 10/22 12:20
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks · 10/22 05:30
Analysts Have Conflicting Sentiments on These Healthcare Companies: Clinuvel Pharmaceuticals (OtherCLVLF) and Telix Pharmaceuticals (OtherTLPPF)
TipRanks · 10/22 00:10
Telix Pharmaceuticals falls -10.1%
TipRanks · 10/21 14:05
More
Webull provides a variety of real-time TLPPF stock news. You can receive the latest news about Telix Pharmaceut through multiple platforms. This information may help you make smarter investment decisions.
About TLPPF
Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Its segments include Therapeutics, Precision Medicine and Telix Manufacturing Solutions. Therapeutics segment develops targeted radionuclide therapies for urologic, neurologic, musculoskeletal and hematological cancers. Precision Medicine segment focuses on bringing diagnostic imaging solutions to market. Precision Medicine segment also includes MedTech and International businesses. Telix Manufacturing Solutions segment is its global network of facilities designed to deliver patient doses worldwide. Its pipeline products include TLX591, TLX250, TLX101, TLX66, TLX592, TLX252, TLX400, Illuccix (68Ga-PSMA-11) and TLX007-CDx.